Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne

An asset write down of NZ$8.5 million (A$7.86m) saw New Zealand-based Rua Bioscience post a loss … Continue reading Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne